IL10 and neoplasm: Therapeutic vaccines incorporating a cytokine, an interleukin-10 signaling inhibitor, drastically increase vaccine-induced antigen-specific T cell responses, attracting more T cells to the tumor site, and furthermore prolong the survival time of tumor-bearing mice [101, 102].